您的位置: 首页 > 农业专利 > 详情页

Combination cancer therapy with hsp90 inhibitory compounds
专利权人:
SYNTA PHARMACEUTICALS CORP.
发明人:
FOLEY KEVIN PAUL,PROIA DAVID,BLACKMAN RONALD K
申请号:
NZ62271310
公开号:
NZ622713A
申请日:
2010.10.19
申请国别(地区):
NZ
年份:
2015
代理人:
摘要:
622713 Disclosed is a method for treating a subject with a cancer selected from breast cancer, ovarian cancer and prostate cancer, comprising administering to the subject an effective amount of paclitaxel or docetaxel and an effective amount of: 3-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(1-methyl-indol-5-yl)-5-hydroxy-[1,2,4]triazole or 5-hydroxy-4-(5-hydroxy-4-(1-methyl-1H-indol-5-yl)-4H-1,2,4-triazol-3-yl)-2-isopropylphenyl dihydrogen phosphate a tautomer, or a pharmaceutically acceptable salt thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充